Howard Marks's BHC Position Overview
Howard Marks (via Oaktree Capital Management Lp) currently holds 1.27 M shares of Bausch Health Companies Inc. (BHC) worth $8.83 M, representing 0.13% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Howard Marks has maintained a strategic position in BHC, demonstrating sustained confidence in this investment. Largest reduction occurred in Q2 2024, reducing 30,000 shares.
Analysis based on 13F filings available since 2013 Q2
Howard Marks's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Howard Marks
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2024 | -30,000 | Reduce 2.31% | 1.27 M | $6.97 |
| Q3 2023 | +1.3 M | New Buy | 1.3 M | $8.22 |
Howard Marks's Bausch Health Companies Investment FAQs
Howard Marks first purchased Bausch Health Companies Inc. (BHC) in Q3 2023, acquiring 1,300,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Howard Marks has held Bausch Health Companies Inc. (BHC) for 10 quarters since Q3 2023.
Howard Marks's largest addition to Bausch Health Companies Inc. (BHC) was in Q3 2023, adding 1,300,000 shares worth $10.69 M.
According to the latest 13F filing for Q4 2025, Howard Marks's firm, Oaktree Capital Management Lp, owns 1,270,000 shares of Bausch Health Companies Inc. (BHC), valued at approximately $8.83 M.
As of the Q4 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.13% of Howard Marks's publicly disclosed stock portfolio, making it one of their key holdings.
Howard Marks's peak holding in Bausch Health Companies Inc. (BHC) was 1,300,000 shares, as reported at the end of Q3 2023.